Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex

Journal of Neuroscience

Volumn 25, Issue 4, 2005, Pages 836-842

  Smolka, Michael N ^a   Schumann, Gunter ^a   Wrase, Jana ^b   Grüsser, Sabine M ^b   Flor, Herta ^a   Mann, Karl ^a   Braus, Dieter F ^c   Goldman, David ^d   Büchel, Christian ^c   Heinz, Andreas ^b  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

^d NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Amygdala; Catecholamine; COMT; Emotion; fMRI; Gene; Prefrontal

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; VALINE;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; EMOTION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; LIMBIC SYSTEM; MALE; NORMAL HUMAN; OXYGEN BLOOD LEVEL; PREFRONTAL CORTEX; PRIORITY JOURNAL; THALAMUS; VISUAL STIMULATION;

ADULT; ALLELES; AMYGDALA; BRAIN; CATECHOL O-METHYLTRANSFERASE; EMOTIONS; FEMALE; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUTATION, MISSENSE; PHOTIC STIMULATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PREFRONTAL CORTEX;

EID: 19944433662     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1792-04.2005     Document Type: Article

References (59)

1. Brody AL, Barsom MW, Bota RG, Saxena S (2001) Prefrontal-subcortical and limbic circuit mediation of major depressive disorder. Semin Clin Neuropsychiatry 6:102-112.
2. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386-389.
3. Charney DS (2004) Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress. Am J Psychiatry 161:195-216.
4. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, Kolachana BS, Hyde TM, Herman MM, Apud J, Egan MF, Kleinman JE, Weinberger DR (2004) Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75:807-821.
5. Cloninger CR, Przybeck TR, Svrakic DM, Wetzel RD (1994) The temperament and character inventory (TCI): a guide to its development and use. St. Louis: Center for Psychobiology of Personality, Washington University.
6. Coull JT (1998) Neural correlates of attention and arousal: insights from electrophysiology, functional neuroimaging and psychopharmacology. Prog Neurobiol 55:343-361.
7. Derogatis LR (1983) Symptom checklist 90-revised/SCL-90-R: administration, scoring and procedures manual II. Baltimore: Clinical Psychometric Research.
8. Domschke K, Freitag CM, Kuhlenbaumer G, Schirmacher A, Sand P, Nyhuis P, Jacob C, Fritze J, Franke P, Rietschel M, Garritsen HS, Fimmers R, Nothen MM, Lesch KP, Stogbauer F, Deckert J (2004) Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women. Int J Neuropsychopharmacol 7:183-188.
9. Drevets WC (2000) Neuroimaging studies of mood disorders. Biol Psychiatry 48:813-829.
10. 108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98:6917-6922.
11. Enoch MA, Schuckit MA, Johnson BA, Goldman D (2003a) Genetics of alcoholism using intermediate phenotypes. Alcohol Clin Exp Res 27:169-176.
12. Enoch MA, Xu K, Ferro E, Harris CR, Goldman D (2003b) Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism. Psychiatry Genet 13:33-41.
13. First MB, Spitzer RL, Gibbon M, Williams JBW (2001) Structured clinical interview for DSM-IV-TR axis I disorders, research version, patient edition (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute.
14. Genovese CR, Lazar NA, Nichols T (2002) Thresholding of statistical maps in functional neuroimaging using the false discovery rate. NeuroImage 15:870-878.
15. Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, Pfaff D, Karayiorgou M (1998) Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA 95:9991-9996.
16. 158 Met genotype and schizophrenia. Arch Gen Psychiatry 60:889-896.
17. Hamilton M (1986) The Hamilton Rating Scale for Depression. In: Assessment of depression (Sartorius N, Ban TA, eds), pp 143-152. Berlin: Springer.
18. Hariri AR, Weinberger DR (2003) Imaging genomics. Br Med Bull 65:259-270.
19. Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, Egan MF, Weinberger DR (2002a) Serotonin transporter genetic variation and the response of the human amygdala. Science 297:400-403.
20. Hariri AR, Mattay VS, Tessitore A, Fera F, Smith WG, Weinberger DR (2002b) Dextroamphetamine modulates the response of the human amygdala. Neuropsychopharmacology 27:1036-1040.
21. Hong J, Shu-Leong H, Tao X, Lap-Ping Y (1998) Distribution of catechol-O-methyltransferase expression in human central nervous system. NeuroReport 9:2861-2864.
22. Karayiorgou M, Sobin C, Blundell ML, Galke BL, Malinova L, Goldberg P, Ott J, Gogos JA (1999) Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder. Biol Psychiatry 45:1178-1189.
23. Kauhanen J, Hallikainen T, Tuomainen TP, Koulu M, Karvonen MK, Salonen JT, Tiihonen J (2000) Association between the functional polymorphism of catechol-O-methyltransferase gene and alcohol consumption among social drinkers. Alcohol Clin Exp Res 24:135-139.
24. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM (1996) Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6:243-250.
25. Lang PJ (1995) The emotion probe. Studies of motivation and attention. Am Psychol 50:372-385.
26. Lang PJ, Öhman A, Vaitl D (1988) The International Affective Picture System (slides). Gainesville, FL: Center for Research in Psychophysiology, University of Florida.
27. Lang PJ, Bradley MM, Fitzsimmons JR, Cuthbert BN, Scott JD, Moulder B, Nangia V (1998) Emotional arousal and activation of the visual cortex: an fMRI analysis. Psychophysiology 35:199-210.
28. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531.
29. Levesque J, Eugene F, Joanette Y, Paquette V, Mensour B, Beaudoin G, Leroux JM, Bourgouin P, Beauregard M (2003a) Neural circuitry underlying voluntary suppression of sadness. Biol Psychiatry 53:502-510.
30. Levesque J, Jeanette Y, Mensour B, Beaudoin G, Leroux JM, Bourgouin P, Beauregard M (2003b) Neural correlates of sad feelings in healthy girls. Neuroscience 121:545-551.
31. Lopez JF, Akil H, Watson SJ (1999) Neural circuits mediating stress. Biol Psychiatry 46:1461-1471.
32. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I, Taskinen J (1995) Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34:4202-4210.
33. Markowitsch HJ, Vandekerckhovel MM, Lanfermann H, Russ MO (2003) Engagement of lateral and medial prefrontal areas in the ecphory of sad and happy autobiographical memories. Cortex 39:643-665.
34. Mataix-Cols D, Cullen S, Lange K, Zelaya F, Andrew C, Amaro E, Brammer MJ, Williams SC, Speckens A, Phillips ML (2003) Neural correlates of anxiety associated with obsessive-compulsive symptom dimensions in normal volunteers. Biol Psychiatry 53:482-493.
35. McNaughton N, Gray JA (2000) Anxiolytic action on the behavioural inhibition system implies multiple types of arousal contribute to anxiety. J Affect Disord 61:161-176.
36. Morris JS, Fristen KJ, Buchel C, Frith CD, Young AW, Calder AJ, Dolan RJ (1998) A neuromodulatory role for the human amygdala in processing emotional facial expressions. Brain 121:47-57.
37. Mynett-Johnson LA, Murphy VE, Claffey E, Shields DC, McKeon P (1998) Preliminary evidence of an association between bipolar disorder in females and the catechol-O-methyltransferase gene. Psychiatry Genet 8:221-225.
38. Ohara K, Nagai M, Suzuki Y, Ohara K (1998a) Low activity allele of catechol-O-methyltransferase gene and Japanese unipolar depression. NeuroReport 9:1305-1308.
39. Ohara K, Nagai M, Suzuki Y, Ochiai M, Ohara K (1998b) No association between anxiety disorders and catechol-O-methyltransferase polymorphism. Psychiatry Res 80:145-148.
40. Palmatier MA, Kang AM, Kidd KK (1999) Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol Psychiatry 46:557-567.
41. Papolos DF, Veit S, Faedda GL, Saito T, Lachman HM (1998) Ultra-ultra rapid cycling bipolar disorder is associated with the low activity catecholamine-O-methyltransferase allele. Mol Psychiatry 3:346-349.
42. Pelletier M, Bouthillier A, Levesque J, Carrier S, Breault C, Paquette V, Mensour B, Leroux JM, Beaudoin G, Bourgouin P, Beauregard M (2003) Separate neural circuits for primary emotions? Brain activity during self-induced sadness and happiness in professional actors. NeuroReport 14:1111-1116.
43. Phan KL, Wager T, Taylor SF, Liberzon I (2002) Functional neuroanatomy of emotion: a meta-analysis of emotion activation studies in PET and fMRI. NeuroImage 16:331-348.
44. Phillips ML, Drevets WC, Rauch SL, Lane R (2003) Neurobiology of emotion perception I: the neural basis of normal emotion perception. Biol Psychiatry 54:504-514.
45. Radloff LS (1997) The CES-D scale: a self report depression scale for research in the general population. Appl Psychol Meas 1:385-401.
46. Rosenkranz JA, Grace AA (1999) Modulation of basolateral amygdala neuronal firing and afferent drive by dopamine receptor activation in vivo. J Neurosci 19:11027-11039.
47. Saxena S, Brody AL, Ho ML, Alborzian S, Maidment KM, Zohrabi N, Ho MK, Huang SC, Wu HM, Baxter Jr LR (2002) Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression. Arch Gen Psychiatry 59:250-261.
48. Spielberger CD, Gorsuch RL, Lushene RE (1970) Manual for the State-Trait-Anxiety Inventory. Palo Alto, CA: Consulting Psychologists.
49. Spielman RS, Weinshilboum RM (1981) Genetics of red cell COMT activity: analysis of thermal stability and family data. Am J Med Genet 10:279-290.
50. Tanaka M, Yoshida M, Emoto H, Ishii H (2000) Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety: basic studies. Eur J Pharmacol 405:397-406.
51. Taylor SF, Phan KL, Decker LR, Liberzon I (2003) Subjective rating of emotionally salient stimuli modulates neural activity. NeuroImage 18:650-659.
52. Tessitore A, Hariri AR, Fera F, Smith WG, Chase TN, Hyde TM, Weinberger DR, Mattay VS (2002) Dopamine modulates the response of the human amygdala: a study in Parkinson's disease. J Neurosci 22:9099-9103.
53. Tiihonen J, Hallikainen T, Lachman H, Saito T, Volavka J, Kauhanen J, Salonen JT, Ryynanen OP, Koulu M, Karvonen MK, Pohjalainen T, Syvalahti E, Hietala J (1999) Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism. Mol Psychiatry 4:286-289.
54. Tunbridge EM, Bannermau DM, Sharp T, Harrison PJ (2004) Catechol-O-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. J Neurosci 24:5331-5335.
55. Vuilleumier P, Armony JL, Clarke K, Husain M, Driver J, Dolan RJ (2002) Neural response to emotional faces with and without awareness: event-related fMRI in a parietal patient with visual extinction and spatial neglect. Neuropsychologia 40:2156-2166.
56. Wang T, Franke P, Neidt H, Cichon S, Knapp M, Lichtermann D, Maier W, Propping P, Nothen MM (2001) Association study of the low-activity allele of catechol-O-methyltransferase and alcoholism using a family-based approach. Mol Psychiatry 6:109-111.
57. Weinshilboum RM, Otterness DM, Szumlanski CL (1999) Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu Rev Pharmacol Toxicol 39:19-52.
58. Woo JM, Yoon KS, Choi YH, Oh KS, Lee YS, Yu BH (2004) The association between panic disorder and the L/L genotype of catechol-O-methyltransferase. J Psychiatry Res 38:365-370.
59. 158 met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 299:1240-1243.